U.S.
approved a generic version of AIDS drug for children
05 November, 2005
U.S. health regulators approved a generic
liquid version of GlaxoSmithKline's AIDS drug Epivir
for use by children under the nation's program to help
fight the dreaded disease in other countries.
The Food and Drug Administration said the generic
drug called lamivudine, made by India's Aurobindo
Pharma Ltd., will not be available in the United States
because of existing patents. The drug is the latest
in a string of tentative AIDS drug approvals this year
for the U.S. program to fight the deadly disease.
Lamivudine is a solution for use in children between
3 months and 16 years. It is type of nucleoside reverse
transcriptase inhibitor, a class of drugs that helps
keep the AIDS virus from reproducing, and is supposed
to be used in combination with other antiretroviral
drugs.
To read more visit:
http://za.today.reuters.com/news/newsArticle.aspx?type=businessNews&storyID=2005-11-05T072504Z_01_ALL526695_RTRIDST_0_OZABS-AIDS-FDA-GENERIC-20051105.XML
|
